NBP
NBP · 최근 17건
8
매수
9
매도
+$13.0M
순매수
거래 내역
Lin Liwei Lorraine
General Counsel · 2026. 7. 8.
+$492K
매수
Hagler Mark Arnold
Chief Commercial Officer · 2026. 7. 8.
+$1.8M
매수
Gupta Srishti
Chief Executive Officer · 2026. 7. 6.
+$6.0M
매수
Xu Cong Claire
SVP, Clinical Development · 2026. 7. 6.
−$4K
매도
Xu Cong Claire
SVP, Clinical Development · 2026. 7. 4.
−
매도
Xu Cong Claire
SVP, Clinical Development · 2026. 7. 4.
−
매도
Fu Wei
Director · 2026. 6. 29.
+$1.8M
매수
Fu Wei
Director · 2026. 6. 29.
+$2.7M
매수
Fu Wei
Director · 2026. 6. 29.
+
매수
Cao Sean Wuxiong
Chief Bus. Development Officer · 2026. 6. 22.
+$277K
매수
Cao Sean Wuxiong
Chief Bus. Development Officer · 2026. 6. 22.
+
매수
Dennis Phillip Andrew
Chief Medical Officer · 2026. 6. 18.
−$6K
매도
Dennis Phillip Andrew
Chief Medical Officer · 2026. 6. 17.
−
매도
Dennis Phillip Andrew
Chief Medical Officer · 2026. 6. 17.
−
매도
Xu Cong Claire
SVP, Clinical Development · 2026. 6. 1.
−$14K
매도
Xu Cong Claire
SVP, Clinical Development · 2026. 5. 30.
−
매도
Xu Cong Claire
SVP, Clinical Development · 2026. 5. 30.
−
매도